Condition | Neoplasms Hemostatic Disorders, Neoplasms by Histologic Type, Immunoproliferative Disorders, PF-06863135, BCMA, Hematologic Diseases, Lymphoproliferative Disorders, BCMA-CD3 bispecific, Neoplasms, Elranatamab, Blood Protein Disorders, Myeloma, bispecific, Plasma Cell, Vascular Diseases, Multiple Myeloma, Hemorrhagic Disorders, bispecific antibody, MagnetisMM-3, relapsed Multiple Myeloma, Cardiovascular Diseases, refractory Multiple Myeloma, Multiple Myeloma, Immune System Diseases, Paraproteinemias |
---|---|
Clinical Study Identifier | TX258544 |
Last Modified on | 20 April 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.